NCT06845930View on ClinicalTrials.gov

Rectal Versus Intramuscular Diclofenac for Pain Relief Following Caesarean Section

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

September 18, 2021

Study Completion Date

September 18, 2021

Conditions
PainreliefPostoperative
Interventions
DRUG

Rectal Diclofenac

Rectal diclofenac, 100mg administered immediately after skin closure then 12 hourly for 24 hours.

DRUG

Intramuscular diclofenac

Intramuscular diclofenac, 7mg administered immediately after skin closure then 12 hourly for 24 hours.

Trial Locations (1)

480101

Alex Ekwueme Federal University Teaching Hospital, Abakaliki

All Listed Sponsors
lead

Assumpta Nnenna Nweke

OTHER_GOV